Esteve Pharmaceuticals SA - Company Profile
Powered by
All the data and insights you need on Esteve Pharmaceuticals SA in one report.
$295
- Save hours of research time and resources with
our up-to-date Esteve Pharmaceuticals SA Strategy Report
- Understand Esteve Pharmaceuticals SA position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on Esteve Pharmaceuticals SA’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
---|---|---|---|---|
25 Apr 2024 | Esteve Pharma to Acquire Hra Pharma Rare Diseases from Perrigo for USD294.11 Million | Acquisition |
Esteve Pharmaceuticals SA
|
Hra Pharma Rare Diseases
|
18 May 2023 | Lubea Acquires 26% Stake in ESTEVE (LABORATORIOS DEL DR ESTEVE SA, Esteve Pharmaceuticals) | Acquisition |
Lubea
|
Esteve Pharmaceuticals SA |
01 Feb 2022 | Esteve Quimica Acquires API Manufacturing Site from Union Quimico Farmaceutica | Asset Transaction |
Esteve Quimica SA
|
Union Quimico Farmaceutica SAU
|
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer